Position in BCYC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$45,809
-$84,143 QoQ
Shares Held
9,873
-46.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,063,537 across 407 Biotechnology names. BCYC ranks #255 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in BCYC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,809 | 9,873 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $129,952 | 18,355 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $62,902 | 8,127 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $53,076 | 7,637 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $59,802 | 7,044 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $107,898 | 7,707 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $190,634 | 8,424 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $134,434 | 6,642 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $388,141 | 15,588 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $182,716 | 10,106 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,376,142 | 68,499 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,453,770 | 96,151 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,853,424 | 87,138 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $2,462,896 | 83,206 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $2,923,524 | 125,689 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $1,400,423 | 83,458 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $434,542 | 9,903 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $172,138 | 2,828 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $56,769 | 1,365 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $62,419 | 2,056 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $38,889 | 1,302 | Shares | Other | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||